ClinicalTrials.Veeva

Menu

Effect of Physiologic Insulin Administration on Insulin Sensitivity and Cognition (MIND-IT)

Pennington Biomedical Research Center logo

Pennington Biomedical Research Center

Status

Enrolling

Conditions

Alzheimer s Disease
Alzheimer Blood Biomarkers
Insulin Sensitivity

Treatments

Other: Physiological Insulin Intervention

Study type

Interventional

Funder types

Other

Identifiers

NCT07265323
PBRC Foundation funds (Other Identifier)
2025-019-PBRC

Details and patient eligibility

About

The goal of this clinical trial is to determine if a weekly delivery of insulin at short intervals lasting up to 2 hours can improve insulin sensitivity and cognition in adults with Alzheimer's Disease. It will also provide information about the safety and feasibility of this intervention.

The main questions it aims to answer are:

Does the intervention improve insulin sensitivity (how the body uses glucose)?

Does the intervention improve cognition, measured by the Montreal Cognitive Assessment (MoCA) and the Revised Memory and Behavior Problems Checklist (RMBPC)?

What changes occur in brain glucose uptake (FDG-PET)?

Participants will:

Receive the intervention once a week for 6 months, with each session lasting up to 2 hours

Complete cognitive assessments. Adverse events will be assessed throughout the study.

Enrollment

8 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Mini Mental State Examination (MMSE) score < 25

Exclusion criteria

  • On daily medication for the specific treatment of anxiety including benzodiazepines.
  • An infant, child, or teenager
  • A pregnant woman
  • A prisoner
  • Having any condition that impedes testing of the study hypothesis or are otherwise deemed to be unsuitable (determined by the investigative team).

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

8 participants in 1 patient group

Physiologic Insulin
Experimental group
Description:
Insulin infusion at five-minute intervals over approximately two hours weekly for six months. Initially infusion will be weekly and then frequency will reduce based on participants' response.
Treatment:
Other: Physiological Insulin Intervention

Trial contacts and locations

1

Loading...

Central trial contact

Candida Rebello, Ph.D.; Tim Gilbert, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems